Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Masao OmataAnn-Lii ChengShiv Kumar Sarin Guidelines Open access 15 June 2017 Pages: 317 - 370
Extracorporeal devices for treatment of refractory pruritus in cholestatic liver disease Roger Williams Editorial 06 June 2017 Pages: 371 - 373
Current progress in host innate and adaptive immunity against hepatitis C virus infection Jijing ShiYuanyuan LiFu-Sheng Wang Review Article 22 June 2017 Pages: 374 - 383
Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease Wonngarm KittanamongkolchaiZiad M. El-ZoghbyNelson Leung Original Article 08 December 2016 Pages: 384 - 389
Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects Yanhua DingHong ZhangJunqi Niu Original Article 30 May 2017 Pages: 390 - 400
Noninvasive serum models to predict significant liver related events in chronic hepatitis C Ragesh Babu ThandasserySaad Al KaabiRajvir Singh Original Article 20 June 2017 Pages: 401 - 408